Rabbit Polyclonal VEGFA antibody. Suitable for ELISA, WB, IHC-P, RIA and reacts with Rat, Pig, Human, Cow samples. Cited in 65 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Cow VEGFA.
View Alternative Names
VEGF, VEGFA, L-VEGF, Vascular permeability factor, VPF
- WB
Unknown
Western blot - Anti-VEGF 164 antibody (AB53465)
All lanes:
Western blot - Anti-VEGF 164 antibody (ab53465) at 1/500 dilution
All lanes:
Human thymus tissue lysate - total protein (<a href='/en-us/products/unavailable/human-thymus-tissue-lysate-total-protein-ab30146'>ab30146</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 27 kDa
Observed band size: 27 kDa,70 kDa
false
Reactivity data
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
VEGF 164 is essential in cellular processes related to vascular growth and blood vessel formation. It is involved in endothelial cell proliferation migration and survival necessary steps for new blood vessel formation. The protein often functions as part of a larger complex that includes co-receptors like neuropilins enhancing its activity and specificity in various tissues. Overall its role is significant in maintaining the structural integrity of the vasculature.
Pathways
VEGF 164 is integrated into angiogenesis and wound healing pathways. It activates several signaling cascades including the PI3K/Akt and MAPK pathways which further involve related proteins like Akt1 and MAPK1. By mediating these pathways VEGF 164 ensures adequate nutrient and oxygen supply to growing tissues or responding to injury.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (65)
Recent publications for all applications. Explore the full list and refine your search
Life (Basel, Switzerland) 14: PubMed38255715
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 11: PubMed37239014
2023
Applications
Unspecified application
Species
Unspecified reactive species
Evidence-based complementary and alternative medicine : eCAM 2022:5183809 PubMed35783525
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of materials science. Materials in medicine 33:19 PubMed35072831
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutical biology 59:1566-1575 PubMed34767490
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 16:3889-3905 PubMed34135583
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 23: PubMed33760199
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:547436 PubMed33584252
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 16:71 PubMed33472642
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 47:732-740 PubMed33416127
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com